PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
Crossref DOI link: https://doi.org/10.1038/s41598-022-15743-0
Published Online: 2022-07-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Min
Sun, Xiao
Wang, Chunli
Wang, Fengdan
Fang, Chuibi
Hu, Zhenlei
Text and Data Mining valid from 2022-07-08
Version of Record valid from 2022-07-08
Article History
Received: 17 May 2022
Accepted: 28 June 2022
First Online: 8 July 2022
Competing interests
: The authors declare no competing interests.